[血管学:2025年有什么新鲜事]
Abdelwahab Boulekbache1, Marc Righini1
1Service d'angiologie et hémostase, Hôpitaux universitaires de Genève, 1211 Genève 14.
Revue medicale suisse
|January 16, 2026
概括
三项2025研究推进了静脉血栓塞栓症 (VTE) 护理. 研究了针对深静脉血栓的年龄调整的D-二分体测试,阿皮克萨班与里瓦罗克萨班的疗效,以及癌症-VTE的延长抗凝药.
科学领域:
- 血管医学 血管医学
- 血液学 血液学 血液学
- 临床血栓形成 临床血栓形成
背景情况:
- 静脉血栓塞栓症 (VTE) 仍然是一个重大的临床挑战.
- 对VTE的诊断策略和治疗方案需要不断改进.
- 在特定患者群体 (如癌症患者) 中,优化抗凝血是至关重要的.
研究的目的:
- 介绍三项主要前性研究的关键发现,这些研究将影响到2025年VTE管理.
- 突出诊断准确性的进步,比较治疗疗效,以及对VTE的扩展抗凝策略.
主要方法:
- 在ADJUST-DVT研究验证了年龄调整的D-二次数门深静脉血栓 (DVT) 诊断.
- 科布拉试验前性地比较了阿皮克萨班和里瓦罗克萨班在急性静脉瘤治疗中.
- 在API-CAT研究中,评估了扩大剂量,降低剂量的apixaban与癌症相关的VTE.
主要成果:
- 经年龄调整的D-二次元值在DVT诊断中显示出有用性.
- 阿皮克萨班和里瓦罗克萨班在急性VTE治疗中显示出相似的安全性和有效性.
- 降低剂量的阿皮克萨班为癌症相关的静脉血栓炎的延长抗凝药提供了潜在的替代方案,平衡了疗效和出血风险.
结论:
- 这些研究为VTE诊断和管理提供了精细的方法.
- 直接口服抗凝剂 (DOAC) 的比较数据为治疗选择提供了信息.
- 个性化抗凝策略,特别是在高危人群中,正在推进VTE护理.
相关概念视频
01:29Angina III: Clinical Manifestations and Assessment
203
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
203
01:26Angina IV: Management
238
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
238
01:20Angina V: Nursing Management
296
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
296
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
942
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
942
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
471
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
01:27Angina II: Classification
332
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
332